As shown in Fig. 1G, H, the overexpression of TRIM25 resulted in an increased percentage of BC cells in the G2/M phase compared with the control, while the inhibition of TRIM25 decreased the percentage of cells in the G2/M phase in breast cancer cells. Here, TRIM25 is linked to breast carcinoma.